Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by deeppocket83on Nov 29, 2016 4:50pm
81 Views
Post# 25530067

RE:RE:I'm out. Will come back later.

RE:RE:I'm out. Will come back later. This is a much better solution. They are raking in tons of money from Salix and Relistor is taking off.  They mentioned this in the earnings. Paul Henderdeen didn't want to sell this Salix, he even mentioned that they don't need to sell in order to keep paying of debt and and operating. Why sell Salix so quickly anyways as they have time. Might as well build up the brand to be even bigger before selling it. Also make sense now why they wrote off the 1billion last earnings.
<< Previous
Bullboard Posts
Next >>